(Q51500170)

English

The NMDA antagonist model for schizophrenia: promise and pitfalls.

scientific article published in July 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

review article

1 reference

stated in

Europe PubMed Central

title

The NMDA antagonist model for schizophrenia: promise and pitfalls. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

0 references

Abi-Saab WM

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

D'Souza DC

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

Moghaddam B

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

Krystal JH

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

publication date

1 July 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

published in

Pharmacopsychiatry

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

volume

31 Suppl 2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

page(s)

104-109

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

Identifiers

DOI

10.1055/S-2007-979354

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

PubMed publication ID

9754841

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9754841

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/9754841

(Q51500170)

The NMDA antagonist model for schizophrenia: promise and pitfalls.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)